Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2002
06/06/2002WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
06/06/2002WO2002022616A3 Alpha v integrin receptor antagonists
06/06/2002WO2002020489A3 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE
06/06/2002WO2002014314A3 Substituted pyrazoles
06/06/2002WO2002012242A3 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/06/2002US20020068752 Fused ring system containing indole as M4 selective aza-anthracene muscarinic receptor antagonists
06/06/2002US20020068748 Diazabicyclooctane derivatives and therapeutic uses thereof
06/06/2002US20020068741 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
06/06/2002US20020068721 Purine derivatives
06/06/2002CA2430305A1 Resolution of trans-7-(hydroxy-methyl)octa-hydro-2h-pyrido-1,2a)pyrazine
06/05/2002EP1211313A2 Modulation of PDE11A activity
06/05/2002EP1210346A2 New active marine alkaloids
06/05/2002EP1210341A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
06/05/2002EP1210339A1 Benzoic acid derivatives for the treatment of diabetes mellitus
06/05/2002EP1210333A2 Novel herbicides
06/05/2002EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands
06/05/2002EP0971920B1 Compounds for inhibition of gastric acid secretion
06/05/2002EP0944628B1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents
06/05/2002EP0934319B1 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS
06/05/2002CN1352646A Camptothecin analogs and methods of preparation thereof
06/04/2002USRE37729 Useful as antipsychotic and analgesic agents.
06/04/2002US6399781 A key intermediate in the production of nevirapine, starting by reacting acetylacetaldehyde dimethyl acetal with malononitrile, in the presence of an ammonium salt catalyst
06/04/2002US6399780 Kinase inhibitors; anticancer agents
06/04/2002US6399616 4-(4-(2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl)ethyl)-1 -piperazinyl)furo(3,2-c)pyridine; combined serotonin reuptake inhibitor and partial agonist of 5-ht receptors; reduced latency; depression
06/04/2002US6399609 Corticotropin releasing factor (crf) antagonists
06/04/2002US6399604 Substituted 4-OXO-napthyridine-3-carboxamides; GABA brain receptor ligands
06/04/2002US6399042 4-fluoroalkyl-3-halophenyl nortropanes
06/04/2002CA2029497C 4-acylaminopyridine derivative
05/2002
05/30/2002WO2002042302A1 Novel sulfonamide-substituted pyrazolopyridine derivatives
05/30/2002WO2002042301A1 Novel pyridine-substituted pyrazolopyridine derivatives
05/30/2002WO2002042300A1 Novel carbamate-substituted pyrazolopyridine derivatives
05/30/2002WO2002042299A1 Novel lactame-substituted pyrazolopyridine derivatives
05/30/2002WO2002042277A1 Novel compounds for use as hiv protease inhibitors
05/30/2002WO2002042273A2 Acid derivatives useful as serine protease inhibitors
05/30/2002WO2002042264A1 3-substituted 2,7-naphthyridin-1-yl derivatives
05/30/2002WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
05/30/2002WO2002041843A2 Antiinflammation agents
05/30/2002WO2002022599A3 Chemokine receptor binding heterocyclic compounds
05/30/2002WO2002004444A3 Heterocycle carboxamides as antiviral agents
05/30/2002WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
05/30/2002WO2001087235A3 Method for producing[18f]fluoride ion
05/30/2002WO2001085686A3 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
05/30/2002US20020065419 Cyclobutenedione compounds
05/30/2002US20020065418 Viral polymerase inhibitors
05/30/2002US20020065413 Anhydrous mirtazapine and process for preparing the same
05/30/2002US20020065292 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity
05/30/2002US20020065290 Used as corticotropin-releasing factor (CRF) antagonists, in therapy and diagnosis of stress related disorders such as post traumatic stress disorder (PTSD) as well as depression, headache and anxiety
05/30/2002US20020065284 Dipeptide derivatives
05/30/2002US20020065278 Non-imidazole aryloxyalkylamines
05/30/2002US20020065268 New compounds, their preparation and use
05/30/2002US20020065267 Compounds, their preparation and use
05/30/2002US20020064794 Modified carbocyanine dyes and their conjugates
05/30/2002CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002CA2429313A1 Novel sulfonamide-substituted pyrazolopyridine derivatives
05/30/2002CA2429309A1 Novel carbamate-substituted pyrazolopyridine derivatives
05/30/2002CA2428459A1 Novel compounds for use as hiv protease inhibitors
05/30/2002CA2428191A1 Acid derivatives useful as serine protease inhibitors
05/30/2002CA2427284A1 Antiinflammation agents
05/29/2002EP1209159A2 Anhydrous mirtazapine and process for preparing the same
05/29/2002EP1209157A1 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
05/29/2002EP1208101A1 Vitronectin receptor antagonists useful for the treatment of strokes
05/29/2002EP1208098A2 Substituted heterocyclyl-2h-chromenes
05/29/2002EP1208097A2 Substituted oxoazaheterocyclyl compounds
05/29/2002EP1208091A1 Benzophenones as inhibitors of reverse transcriptase
05/29/2002EP1208085A2 Benzanilides as potassium channel openers
05/29/2002DE10038672A1 New perylene tricarboxylic acid imide derivatives, useful as fluorescence dyes for dyeing natural and synthetic materials
05/29/2002CN1351604A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
05/29/2002CN1351602A New pharmaceutically active compounds
05/29/2002CN1351601A Heterocyclic compounds binding chemotactic factor receptor
05/29/2002CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors
05/29/2002CN1350787A Synergistic herbicidal composition and method
05/29/2002CN1350786A Synergistic herbicidal composition and method
05/29/2002CN1085666C 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyro sine kinase medicated cellular proliferation
05/28/2002US6395747 Ibudilast
05/28/2002US6395746 Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
05/28/2002US6395745 Stable, crystal structure; plant extract
05/28/2002US6395733 Anticancer agents; antiproliferative agents
05/28/2002US6395727 Method of treating Bulimia Nervosa and related eating disorders by administration of atypical antipsychotic medications
05/28/2002US6395724 Multibinding inhibitors of cyclooxygenase-2
05/28/2002US6395683 Heterocyclylbenzonitriles
05/28/2002CA2203618C New metalloprotease inhibitors, their preparation process and the pharmaceutical compounds that contain them
05/28/2002CA2181377C Tetracyclic derivatives, process of preparation and use
05/27/2002CA2346195A1 Anhydrous mirtazapine and process for preparing the same
05/23/2002WO2002040505A2 Dibenzoxazepine alpha v integrin receptor antagonist
05/23/2002WO2002040486A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
05/23/2002WO2002040484A2 Novel imidazole derivatives, production method thereof and use thereof
05/23/2002WO2002040480A2 Crf receptor antagonists and methods relating thereto
05/23/2002WO2002040479A1 Anti-helicobacterial agents
05/23/2002WO2002040478A1 Dehalogeno compounds
05/23/2002WO2002040477A2 Saframycins, analogues and uses thereof
05/23/2002WO2002040476A1 Pyridyl-substituted triazoles as tgf inhibitors
05/23/2002WO2002040471A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
05/23/2002WO2002040455A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
05/23/2002WO2002040027A1 Treatment of premature ejaculation
05/23/2002WO2002014313A3 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments
05/23/2002WO2002000638A3 Substituted phthalides as anti-convulsive drugs
05/23/2002WO2001087882A3 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
05/23/2002WO2001083479A3 Process for the preparation of pyrazolopyridine derivatives
05/23/2002US20020061913 Bicyclic amine derivatives